Propionic Acidemia Therapeutic Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Propionic Acidemia Therapeutic Market is segmented By Therapeutics (Gene Therapy, Enzyme Replacement Therapy), By Molecule Type (Small Molecules, Biologics), By Administration Route (Oral, Intravenous), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD million) for the above-mentioned.
Propionic Acidemia Therapeutic Market Size
Market Size in USD
CAGR7.8%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 7.8% |
| Market Concentration | Medium |
| Major Players | HemoShear Therapeutics, LogicBio Therapeutics, Roche, Astellas Pharma, Moderna Therapeutics |
please let us know !
Propionic Acidemia Therapeutic Market Analysis
The propionic acidemia therapeutic market is estimated to be valued at USD 600.6 Mn in 2024 and is expected to reach USD 1,016.6 Mn by 2031, growing at a compound annual growth rate (CAGR) of 7.8% from 2024 to 2031. Increase in research and development activities for developing newer treatments for propionic acidemia is a major factor anticipated to drive market growth. Several pipeline drugs are under development which upon approval will provide novel treatment options and boost market revenues.